Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
DexCom (DXCM)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for DXCM as compared to
Top Competitors
Medical Instruments & Supplies
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
INCOME STATEMENT (
See all
)
Revenue
►
23.3M
AVG
EBITDA
►
-45.8M
LOW
Net Income
►
-55.4M
LOW
Revenue Growth
►
219.5%
VERY HIGH
Operating Margin
►
-208.9%
VERY LOW
Net Margin
►
-238%
VERY LOW
Revenue, Gross Profit, and Gross Margin
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
-6.93
Current Ratio
►
2.47
AVG
Quick Ratio
►
2.36
AVG
Interest Coverage Ratio
►
-7.12
AVG
Book Value Per Share
►
-0.198
Cash Per Share
►
0.138
Loading...
STOCK SUMMARY
Open
7.05
Day Range
7.00
-
7.20
52 Week Range
1.83
-
8.96
Volume
68K
Avg Volume (3 mo)
198K
Shares Outstanding
46.0M
Market Cap
322M
VALUATION
Price to Earnings (P/E)
►
-6.14
Price to Book (P/B)
►
-37.4
Price to Sales (P/S)
►
14.6
VERY HIGH
Return on Assets (ROA)
►
-100.2%
VERY LOW
Return on Equity (ROE)
►
-902.9%
VERY LOW
EV/EBITDA
►
-8.55
Dividend Yield
0%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
0.2%
Net Insider Buying 6mo
0.2%
Net Insider Buying 1yr
1.2%
Held by insiders
23.3%
Held by institutions
83%
No Sales Breakout Data.